Please assess the completion status of the following clinical trial:

Trial Title: OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria includes, but is not limited to:~* Subject is a male or female aged 6 months to 17 years, inclusive~* Subject has a clinical diagnosis of bilateral middle ear effusion requiring tympanostomy tube placement~* Subject's caregiver is willing to comply with the protocol and attend all study visits~Exclusion Criteria includes, but is not limited to:~* Subject has a history of prior ear or mastoid surgery, not including myringotomy or myringotomy with tympanostomy tube placement~* Subject has a history of sensorineural hearing loss~* Subject has a history of chronic or recurrent bacterial infections other than otitis media that likely will require treatment with antibiotics during the course of the study

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- OTO-201 (Type: EXPERIMENTAL): OTO-201: Single, intratympanic injection:~One injection of 6 mg OTO-201 (ciprofloxacin in poloxamer 407) into each ear during surgery.
- Sham (Type: SHAM_COMPARATOR): Sham: Simulated single, intratympanic injection:~One sham injection into each ear during surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).